Peptides DB
Research-centric peptide and protocol reference hub
Study 62 of 65HCG (Human Chorionic Gonadotropin) literatureJournal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · Observational2026

Endometrial ultrasound features associated with methotrexate success in tubal ectopic pregnancy: a prospective case series.

Endometrial ultrasound features such as thickness and echo pattern may provide additional insights into the likelihood of methotrexate success in ectopic pregnancies, but further analysis is needed to confirm their independent predictive value.

Read at Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and GynaecologyAdd to compare

Where it sits

this study against the rest of the hcg (human chorionic gonadotropin) corpus
9
Preclinical
51
Observational · this one
0
Open-label
3
Randomised
2
Reviews

Summary and findings

This study measured the association between endometrial ultrasound features and treatment success in women with tubal ectopic pregnancy receiving a single dose of methotrexate. A total of 177 women were included, and treatment success was defined as a ≥15% decline in serum β-hCG from day 4 to day 7 post-treatment. The study found that treatment success occurred in 53.1% of participants.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
53.1% treatment success in 177 women.2026

Abstract

The authors’ words, as Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology supplied them

<h4>Background</h4>Ectopic pregnancy is an important cause of maternal morbidity in early pregnancy. Single-dose methotrexate is commonly used for haemodynamically stable women with unruptured tubal ectopic pregnancy, but treatment success varies. The association between pre-treatment endometrial ultrasonographic features and treatment outcome remains uncertain.<h4>Methods</h4>This prospective case series included 177 women with confirmed tubal ectopic pregnancy who received a single intramuscular dose of methotrexate (50 mg/m<sup>2</sup>) at two tertiary hospitals in Isfahan, Iran, between January and December 2024. Transvaginal ultrasonography was used to measure endometrial thickness and classify the endometrial echo pattern as homogeneous or triple-layer. Treatment success was defined as a ≥ 15% decline in serum β-hCG from day 4 to day 7 after treatment, followed by weekly monitoring until the concentration became undetectable. Associations with treatment success were assessed using univariable logistic regression.<h4>Results</h4>Treatment success occurred in 94 of 177 women (53.1%). Responders had lower median baseline β-hCG concentrations (500 versus 1400 mIU/mL; <i>P</i> < 0.001), thinner endometrium (7 versus 9 mm; <i>P</i> = 0.009), and a higher proportion of homogeneous endometrial appearance (65.9 versus 49.4%; <i>P</i> = 0.026). In univariable logistic regression, baseline β-hCG (<i>P</i> = 0.003), ectopic pregnancy size (<i>P</i> = 0.013), and homogeneous endometrial appearance (<i>P</i> = 0.027) were significantly associated with treatment success; endometrial thickness showed borderline evidence of association (<i>P</i> = 0.0498).<h4>Conclusion</h4>Baseline β-hCG, ectopic pregnancy size, and endometrial appearance were associated with single-dose methotrexate success in univariable analyses, while endometrial thickness showed a borderline association. Because no multivariable model was fitted, these findings should not be interpreted as independent predictors. Endometrial ultrasonographic features may provide supportive information alongside established clinical factors such as baseline β-hCG.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the HCG (Human Chorionic Gonadotropin) corpus

BEarly pembrolizumab as salvage therapy in EMA-CO-refractory ultra-high-risk gestational choriocarcinoma.Seminars in oncology · 2026 · n=1 · Not reported in abstract.HumanBEndometrial ultrasound features associated with methotrexate success in tubal ectopic pregnancy: a prospective case series.Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2024 · n=177 · Treatment success occurred in 94 of 177 women (53.1%).HumanBSuccessful fertility-preserving management of a viable cesarean scar ectopic pregnancy: a case report.Case reports in women's health · 2026 · n=1 · Estimated blood loss of 20 mL.HumanCSR-18292 Alters Oocyte Competence and Ovarian Transcriptomic Dynamics in Female Micebiorxiv-preprint · 2026 · Not reported in abstract.AnimalBHigh-grade endometrioid carcinoma arising from uterine serosal endometriosis with focal choriocarcinomatous differentiation and embryonal carcinoma-like morphology: a case report and literature reviewbiorxiv-preprint · 2023 · n=1 · Serum β-hCG remained persistently below 1 mIU/mL throughout follow-up.HumanBEfficacy of hysteroscopic curettage and niche resection in type II and III cesarean scar pregnancies.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2026 · n=105 · 20 (15,25) min vs 25 (20,31) min operation time, p=0.001Human